- Home
- QUIK vs SRZN Comparison
QUIK vs SRZN Comparison
Compare QUIK & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUIK
- SRZN
- Stock Information
- Founded
- QUIK 1988
- SRZN 2015
- Country
- QUIK United States
- SRZN United States
- Employees
- QUIK N/A
- SRZN N/A
- Industry
- QUIK Semiconductors
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- QUIK Technology
- SRZN Health Care
- Exchange
- QUIK Nasdaq
- SRZN Nasdaq
- Market Cap
- QUIK 87.3M
- SRZN 82.8M
- IPO Year
- QUIK 1997
- SRZN N/A
- Fundamental
- Price
- QUIK $5.90
- SRZN $8.35
- Analyst Decision
- QUIK Strong Buy
- SRZN Strong Buy
- Analyst Count
- QUIK 3
- SRZN 2
- Target Price
- QUIK $11.53
- SRZN $38.50
- AVG Volume (30 Days)
- QUIK 94.9K
- SRZN 10.4K
- Earning Date
- QUIK 05-13-2025
- SRZN 05-20-2025
- Dividend Yield
- QUIK N/A
- SRZN N/A
- EPS Growth
- QUIK N/A
- SRZN N/A
- EPS
- QUIK N/A
- SRZN N/A
- Revenue
- QUIK $20,112,000.00
- SRZN $10,655,000.00
- Revenue This Year
- QUIK $22.56
- SRZN N/A
- Revenue Next Year
- QUIK $21.66
- SRZN N/A
- P/E Ratio
- QUIK N/A
- SRZN N/A
- Revenue Growth
- QUIK N/A
- SRZN N/A
- 52 Week Low
- QUIK $4.26
- SRZN $6.00
- 52 Week High
- QUIK $16.13
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- QUIK 59.62
- SRZN 33.48
- Support Level
- QUIK $5.31
- SRZN $9.96
- Resistance Level
- QUIK $5.98
- SRZN $11.56
- Average True Range (ATR)
- QUIK 0.35
- SRZN 0.72
- MACD
- QUIK 0.12
- SRZN -0.13
- Stochastic Oscillator
- QUIK 83.53
- SRZN 1.53
About QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).